These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34466510)

  • 1. Mismeasured Covariate in the Long-Term Survival of Colorectal Cancer.
    Azizmohammad Looha M; Pourhoseingholi MA; Hosseini SV; Khodakarim S
    Galen Med J; 2019; 8():e1413. PubMed ID: 34466510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of a non-parametric non-mixture cure rate model for analyzing the survival of patients with colorectal cancer in Iran.
    Azizmohammad Looha M; Pourhoseingholi MA; Nasserinejad M; Najafimehr H; Zali MR
    Epidemiol Health; 2018; 40():e2018045. PubMed ID: 30220192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of prognostic factors in long-term survival of male and female patients with colorectal cancer using non-mixture cure model based on the Weibull distribution.
    Azizmohammad Looha M; Zarean E; Masaebi F; Pourhoseingholi MA; Zali MR
    Surg Oncol; 2021 Sep; 38():101562. PubMed ID: 33862578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic lymph node ratio as an independent prognostic variable in colorectal cancer: study of 113 patients.
    Priolli DG; Cardinalli IA; Pereira JA; Alfredo CH; Margarido NF; Martinez CA
    Tech Coloproctol; 2009 Jun; 13(2):113-21. PubMed ID: 19484349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic lymph node ratio (LNR) as a prognostic variable in colorectal cancer patients undergoing laparoscopic resection.
    Greenberg R; Itah R; Ghinea R; Sacham-Shmueli E; Inbar R; Avital S
    Tech Coloproctol; 2011 Sep; 15(3):273-9. PubMed ID: 21695442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of primary tumor lymph node ratio with burden of liver metastases and survival in stage IV colorectal cancer.
    Ahmad A; Reha J; Saied A; Espat NJ; Somasundar P; Katz SC
    Hepatobiliary Surg Nutr; 2017 Jun; 6(3):154-161. PubMed ID: 28652998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abdominal lymph node recurrence from colorectal cancer: Resection should be considered as a curative treatment in patients with controlled disease.
    Zarzavadjian Le Bian A; Genser L; Tabchouri N; Fillol C; Laforest A; Tresallet C; Ouaissi M; Fuks D
    Surg Oncol; 2020 Dec; 35():206-210. PubMed ID: 32911212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian cure fraction models with measurement error in the scale mixture of normal distribution.
    Marinho ARS; Loschi RH
    Stat Methods Med Res; 2020 Sep; 29(9):2411-2444. PubMed ID: 31928318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node ratio as an independent prognostic indicator in stage III colorectal cancer: especially for fewer than 12 lymph nodes examined.
    Jiang K; Zhu Y; Liu Y; Ye Y; Xie Q; Yang X; Wang S
    Tumour Biol; 2014 Nov; 35(11):11685-90. PubMed ID: 25139098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional Lymph Nodes Status and Ratio of Metastatic to Examined Lymph Nodes Correlate with Survival in Stage IV Colorectal Cancer.
    Ahmed S; Leis A; Chandra-Kanthan S; Fields A; Zaidi A; Abbas T; Le D; Reeder B; Pahwa P
    Ann Surg Oncol; 2016 Jul; 23(7):2287-94. PubMed ID: 27016291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of lymph node ratio in stage IV colorectal cancer.
    Derwinger K; Gustavsson B
    World J Surg Oncol; 2008 Dec; 6():127. PubMed ID: 19046414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inference in a survival cure model with mismeasured covariates using a simulation-extrapolation approach.
    Bertrand A; Legrand C; Carroll RJ; De Meester C; Van Keilegom I
    Polit Anal; 2017 Mar; 104(1):31-50. PubMed ID: 29151774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Prediction Model for Tumor Recurrence in Stage II-III Colorectal Cancer Patients: From a Machine Learning Model to Genomic Profiling.
    Chen PC; Yeh YM; Lin BW; Chan RH; Su PF; Liu YC; Lee CT; Chen SH; Lin PC
    Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Log odds of positive lymph nodes is prognostically equivalent to lymph node ratio in non-metastatic colon cancer.
    Baqar AR; Wilkins S; Wang W; Oliva K; McMurrick P
    BMC Cancer; 2020 Aug; 20(1):762. PubMed ID: 32795292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Factors Affecting Short- and Long-Term Recurrence-Free Survival of Patients with Rectal Cancer using Cure Models: A Cohort Study.
    Hosseini SV; Rezaianzadeh A; Rahimikazerooni S; Ghahramani L; Bananzadeh A
    Iran J Med Sci; 2020 Sep; 45(5):333-340. PubMed ID: 33060876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node ratio may predict relapse free survival and overall survival in patients with stage II & III colorectal carcinoma.
    Zekri J; Ahmad I; Fawzy E; Elkhodary TR; Al-Gahmi A; Hassouna A; El Sayed ME; Ur Rehman J; Karim SM; Bin Sadiq B
    Hepatogastroenterology; 2015; 62(138):291-4. PubMed ID: 25916051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the cure proportion of colorectal cancer and related factors after surgery in patients using parametric cure models.
    Izadi N; Koohi F; Safarpour M; Naseri P; Rahimi S; Khodakarim S
    Gastroenterol Hepatol Bed Bench; 2020; 13(2):125-132. PubMed ID: 32308933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Discrimination of Alternative Lymph Node Classification Systems for Patients with Radically Resected Non-Metastatic Colorectal Cancer: A Cohort Study from a Single Tertiary Referral Center.
    Prassas D; Verde PE; Pavljak C; Rehders A; Krieg S; Luedde T; Knoefel WT; Krieg A
    Cancers (Basel); 2021 Aug; 13(15):. PubMed ID: 34359803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of the lymph node ratio in stage IV colorectal cancer patients who have undergone curative resection.
    Ozawa T; Ishihara S; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Hata K; Kawai K; Nozawa H; Kanazawa T; Kazama S; Yamaguchi H; Sunami E; Kitayama J; Watanabe T
    Ann Surg Oncol; 2015 May; 22(5):1513-9. PubMed ID: 25398278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymph Node Ratio Predicts Long-Term Survival in Lymph Node-Positive Breast Cancer.
    Sakin A; Aldemir MN
    Eur J Breast Health; 2020 Oct; 16(4):270-275. PubMed ID: 33062968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.